| Primary |
| Induction Of Anaesthesia |
26.8% |
| Anaesthesia |
18.9% |
| General Anaesthesia |
11.9% |
| Sedation |
10.6% |
| Maintenance Of Anaesthesia |
7.8% |
| Induction And Maintenance Of Anaesthesia |
4.2% |
| Premedication |
2.5% |
| Hypertension |
2.1% |
| Epidural Anaesthesia |
2.0% |
| Antibiotic Prophylaxis |
1.9% |
| Hypotonia |
1.8% |
| Analgesic Therapy |
1.7% |
| Anaesthetic Premedication |
1.6% |
| Drug Use For Unknown Indication |
1.3% |
| Hypotension |
1.2% |
| Pain |
1.0% |
| Infection Prophylaxis |
0.8% |
| Sedative Therapy |
0.7% |
| Prophylaxis |
0.7% |
| Epilepsy |
0.6% |
|
| Anaphylactic Shock |
27.6% |
| Shock |
9.9% |
| Rhabdomyolysis |
8.0% |
| Delayed Recovery From Anaesthesia |
6.5% |
| Tachycardia |
4.8% |
| Propofol Infusion Syndrome |
4.1% |
| Pyrexia |
3.9% |
| Circulatory Collapse |
3.7% |
| Rash |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Cardiac Arrest |
3.4% |
| Hyperthermia Malignant |
3.4% |
| Respiratory Arrest |
2.7% |
| Septic Shock |
2.7% |
| Hypotension |
2.3% |
| Erythema |
2.1% |
| Urticaria |
2.1% |
| Generalised Erythema |
1.9% |
| Post Procedural Complication |
1.9% |
| Bronchospasm |
1.8% |
|
| Secondary |
| Induction Of Anaesthesia |
13.7% |
| Anaesthesia |
13.2% |
| Product Used For Unknown Indication |
10.2% |
| Sedation |
10.2% |
| General Anaesthesia |
9.3% |
| Drug Use For Unknown Indication |
7.8% |
| Maintenance Of Anaesthesia |
5.7% |
| Prophylaxis |
4.0% |
| Analgesic Therapy |
3.9% |
| Blood Pressure Management |
3.3% |
| Premedication |
2.6% |
| Shock |
2.2% |
| Infection Prophylaxis |
2.1% |
| Flushing |
1.9% |
| Hypertension |
1.8% |
| Muscle Relaxant Therapy |
1.7% |
| Induction And Maintenance Of Anaesthesia |
1.7% |
| Polyuria |
1.6% |
| Epidural Anaesthesia |
1.6% |
| Pain |
1.4% |
|
| Delayed Recovery From Anaesthesia |
11.3% |
| Anaphylactic Shock |
9.2% |
| Pyrexia |
8.4% |
| Hypotension |
6.7% |
| Rhabdomyolysis |
6.7% |
| Shock |
6.2% |
| Tachycardia |
5.1% |
| Propofol Infusion Syndrome |
4.9% |
| Cardiac Arrest |
4.6% |
| Sepsis |
4.6% |
| Stress Cardiomyopathy |
4.3% |
| Urticaria |
4.0% |
| Bundle Branch Block Left |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Hyperthermia Malignant |
3.2% |
| Restlessness |
3.2% |
| Cardio-respiratory Arrest |
2.7% |
| Cytolytic Hepatitis |
2.7% |
| Erythema |
2.7% |
| Pancreatitis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.8% |
| Drug Use For Unknown Indication |
26.0% |
| Anaesthesia |
5.4% |
| Prophylaxis |
4.4% |
| General Anaesthesia |
4.3% |
| Sedation |
3.9% |
| Pain |
3.4% |
| Surgery |
2.0% |
| Induction Of Anaesthesia |
1.9% |
| Hypertension |
1.9% |
| Maintenance Of Anaesthesia |
1.6% |
| Osteoporosis |
1.6% |
| Epilepsy |
1.6% |
| Idiopathic Pulmonary Fibrosis |
1.6% |
| Pneumonia |
1.6% |
| Fluid Replacement |
1.5% |
| Coronary Artery Bypass |
1.5% |
| Infection Prophylaxis |
1.3% |
| Systemic Lupus Erythematosus |
1.3% |
| Acute Myocardial Infarction |
1.3% |
|
| Tachycardia |
9.5% |
| Wound Infection Staphylococcal |
8.0% |
| Toxic Epidermal Necrolysis |
7.6% |
| Ventricular Tachycardia |
7.6% |
| Sepsis |
6.1% |
| Vomiting |
5.7% |
| Thrombocytopenia |
5.3% |
| Injury |
5.0% |
| Rhabdomyolysis |
5.0% |
| Renal Failure |
4.2% |
| Respiratory Failure |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Respiratory Disorder |
3.8% |
| Shock |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Rash |
3.4% |
| Urinary Tract Infection |
3.4% |
| Anxiety |
3.1% |
| Obstructive Airways Disorder |
3.1% |
| Status Epilepticus |
3.1% |
|
| Interacting |
| Infection |
25.0% |
| Sedation |
25.0% |
| Hypertension |
15.0% |
| General Anaesthesia |
10.0% |
| Acute Lymphocytic Leukaemia Recurrent |
5.0% |
| Anaesthesia |
5.0% |
| Disseminated Intravascular Coagulation |
5.0% |
| Induction Of Anaesthesia |
5.0% |
| Sedative Therapy |
5.0% |
|
| Shock |
40.0% |
| Drug Interaction |
20.0% |
| Pyrexia |
20.0% |
| Sinusitis |
20.0% |
|
